Adiponectin and the Control of Female Reproductive Functions

Vitamins and Hormones

Volumn 90, Issue , 2012, Pages 239-287

  Palin, Marie France ^a   Bordignon, V Vilceu ^b   Murphy, Bruce D ^c  

^a AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adiponectin; Female; Ovarian functions; Pregnancy; Reproduction

Indexed keywords

EID: 84866603796     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-398313-8.00010-5     Document Type: Chapter

References (255)

1. Agarwal N., Rice S.P.L., Bolusani H., Luzio S.D., Dunseath G., Ludgate M., et al. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: A randomized, placebo-controlled, crossover trial. Journal of Clinical Endocrinology and Metabolism 2010, 95:722.
2. Andersen K.K., Frystyk J., Wolthers O.D., Heuck C., Flyvbjerg A. Gender differences of oligomers and total adiponectin during puberty: A cross-sectional study of 859 Danish school children. Journal of Clinical Endocrinology and Metabolism 2007, 92:1857.
3. Archanco M., Gomez-Ambrosi J., Tena-Sempere M., Fruhbeck G., Burrell M.A. Expression of leptin and adiponectin in the rat oviduct. Journal of Histochemistry and Cytochemistry 2007, 55:1027.
4. Ardawi M.S., Rouzi A.A. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertility and Sterility 2005, 83:1708.
5. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999, 257:79.
6. Aroda V., Ciaraldi T.P., Chang S.A., Dahan M.H., Chang R.J., Henry R.R. Circulating and cellular adiponectin in polycystic ovary syndrome: Relationship to glucose tolerance and insulin action. Fertility and Sterility 2008, 89:1200.
7. Asimakopoulos B., Milousis A., Gioka T., Kabouromiti G., Gianisslis G., Troussa A., et al. Serum pattern of circulating adipokines throughout the physiological menstrual cycle. Endocrine Journal 2009, 56:425.
8. Barber T.M., Hazell M., Christodoulides C., Golding S.J., Alvey C., Burling K., et al. Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: Associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition. Journal of Clinical Endocrinology and Metabolism 2008, 93:2859.
9. Barber T.M., McCarthy M.I., Wass J.A., Franks S. Obesity and polycystic ovary syndrome. Clinical Endocrinology 2006, 65:137.
10. Benaitreau D., Dieudonné M.N., Dos Santos E., Leneveu M.C., de Mazancourt P., Pecquery R. Antiproliferative effects of adiponectin on human trophoblastic cell lines JEG-3 and BeWo. Biology of Reproduction 2009, 80:1107.
11. Benaitreau D., Dos Santos E., Leneveu M.C., Alfaidy N., Feige J.J., de Mazancourt P., et al. Effects of adiponectin on human trophoblast invasion. Journal of Endocrinology 2010, 207:45.
12. Benaitreau D., Dos Santos E., Leneveu M.C., de Mazancourt P., Pecquery R., Dieudonné M.N. Adiponectin promotes syncytialisation of BeWo cell line and primary trophoblast cells. Reproductive Biology and Endocrinology 2010, 8:128.
13. Ben-Ziv R.G., Hod M. Gestational diabetes mellitus. Fetal and Maternal Medicine Review 2008, 19:245.
14. Bersinger N.A., Birkhauser M.H., Wunder D.M. Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles. Gynecological Endocrinology 2006, 22:479.
15. Bik W., Baranowska-Bik A., Wolinska-Witort E., Chmielowska M., Martynska L., Baranowska B. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome. Gynecological Endocrinology 2007, 23:325.
16. Bjursell M., Ahnmark A., Bohlooly-Y M., William-Olsson L., Rhedin M., Peng X.R., et al. Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 2007, 56:583.
17. Bottner A., Kratzsch J., Muller G., Kapellen T.M., Bluher S., Keller E., et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. The Journal of Clinical Endocrinology and Metabolism 2004, 89:4053.
18. Bouchard L., Guay S.P., St-Pierre J., Hivert M.F., Perrron P., Brisson D. Placental adiponectin gene DNA methylation levels is correlated with maternal blood glucose concentration. Canadian Journal of Diabetes 2011, 35(2):30.
19. Brassard M., AinMelk Y., Baillargeon J.P. Basic infertility including polycystic ovary syndrome. The Medical Clinics of North America 2008, 92:1163.
20. Brewer C.J., Balen A.H. The adverse effects of obesity on conception and implantation. Reproduction 2010, 140:347.
21. Briana D.D., Malamitsi-Puchner A. Reviews: Adipocytokines in normal and complicated pregnancies. Reproductive Sciences 2009, 16:921.
22. Brochu-Gaudreau K., Rehfeldt C., Blouin R., Bordignon V., Murphy B.D., Palin M.F. Adiponectin action from head to toe. Endocrine 2010, 37:11.
23. Bromhead C., Miller J.H., McDonald F.J. Regulation of T-cadherin by hormones, glucocorticoid and EGF. Gene 2006, 374:58.
24. Brufani C., Tozzi A., Fintini D., Ciampalini P., Grossi A., Fiori R., et al. Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects. European Journal of Endocrinology 2009, 160:769.
25. Budak E., Fernandez Sanchez M., Bellver J., Cervero A., Simon C., Pellicer A. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertility and Sterility 2006, 85:1563.
26. Caja S., Torrente M., Martinez I., Abelenda M., Puerta M. Adiponectin values are unchanged during pregnancy in rats. Journal of Endocrinological Investigation 2005, 28:609.
27. Caminos J.E., Nogueiras R., Gallego R., Bravo S., Tovar S., Garcia-Caballero T., et al. Expression and regulation of adiponectin and receptor in human and rat placenta. Journal of Clinical Endocrinology and Metabolism 2005, 90:4276.
28. Campos D.B., Palin M.F., Bordignon V., Murphy B.D. The 'beneficial' adipokines in reproduction and fertility. International Journal of Obesity 2008, 32:223.
29. Carmina E., Orio F., Palomba S., Cascella T., Longo R.A., Colao A.M., et al. Evidence for altered adipocyte function in polycystic ovary syndrome. European Journal of Endocrinology 2005, 152:389.
30. Carmina E., Orio F., Palomba S., Longo R.A., Cascella T., Colao A., et al. Endothelial dysfunction in PCOS: Role of obesity and adipose hormones. American Journal of Medicine 2006, 119:356. e1.
31. Chabrolle C., Tosca L., Crochet S., Tesseraud S., Dupont J. Expression of adiponectin and its receptors (AdipoR1 and AdipoR2) in chicken ovary: Potential role in ovarian steroidogenesis. Domestic Animal Endocrinology 2007, 33:480.
32. Chabrolle C., Tosca L., Dupont J. Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction 2007, 133:719.
33. Chabrolle C., Tosca L., Ramé C., Lecomte P., Royère D., Dupont J. Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertility and Sterility 2009, 92:1988.
34. Chalvatzas N., Dafopoulos K., Kosmas G., Kallitsaris A., Pournaras S., Messinis I.E. Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertility and Sterility 2009, 91:1189.
35. Chandrasekar B., Boylston W.H., Venkatachalam K., Webster N.J.G., Prabhu S.D., Valente A.J. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression. Journal of Biological Chemistry 2008, 283:24889.
36. Chappaz E., Albornoz M.S., Campos D., Che L., Palin M.F., Murphy B.D., et al. Adiponectin enhances in vitro development of swine embryos. Domestic Animal Endocrinology 2008, 35:198.
37. Chen J., Tan B., Karteris E., Zervou S., Digby J., Hillhouse E.W., et al. Secretion of adiponectin by human placenta: Differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006, 49:1292.
38. Chu M.C., Cosper P., Nakhuda G.S., Lobo R.A. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertility and Sterility 2006, 86:1669.
39. Chu M.C., Cosper P., Orio F., Carmina E., Lobo R.A. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. American Journal of Obstetrics and Gynecology 2006, 194:100.
40. Cikos S., Burkus J., Bukovska A., Fabian D., Rehak P., Koppel J. Expression of adiponectin receptors and effects of adiponectin isoforms in mouse preimplantation embryos. Human Reproduction 2010, 25:2247.
41. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 2003, 46:459.
42. Colombel A., Charbonnel B. Weight gain and cardiovascular risk factors in the post-menopausal women. Human Reproduction 1997, 12:134.
43. Combs T.P., Berg A.H., Rajala M.W., Klebanov S., Iyengar P., Jimenez-Chillaron J.C., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003, 52:268.
44. Corbetta S., Bulfamante G., Cortelazzi D., Barresi V., Cetin I., Mantovani G., et al. Adiponectin expression in human fetal tissues during mid- and late gestation. Journal of Clinical Endocrinology and Metabolism 2005, 90:2397.
45. Cortelazzi D., Corbetta S., Ronzoni S., Pelle F., Marconi A., Cozzi V., et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clinical Endocrinology 2007, 66:447.
46. Crosignani P.G., Colombo M., Vegetti W., Somigliana E., Gessati A., Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: Parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Human Reproduction 2003, 18:1928.
47. Crosignani P.G., Nicolosi A.E. Polycystic ovarian disease: Heritability and heterogeneity. Human Reproduction Update 2001, 7:3.
48. Cseh K., Baranyi E., Melczer Z., Kaszas E., Palik E., Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 2004, 27:274.
49. D'Anna R., Baviera G., Corrado F., Giordano D., De Vivo A., Nicocia G., et al. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG: An International Journal of Obstetrics and Gynaecology 2006, 113:1264.
50. Dafopoulos K., Sourlas D., Kallitsaris A., Pournaras S., Messinis I.E. Blood ghrelin, resistin, and adiponectin concentrations during the normal menstrual cycle. Fertility and Sterility 2009, 92:1389.
51. Dalamaga M., Srinivas S.K., Elovitz M.A., Chamberland J., Mantzoros C.S. Serum adiponectin and leptin in relation to risk for preeclampsia: Results from a large case-control study. Metabolism 2011, 60:1539.
52. Daoud G., Amyot M., Rassart E., Masse A., Simoneau L., Lafond J. ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. The Journal of Physiology 2005, 566(2):409.
53. Deepa S.S., Dong L.Q. APPL1: Role in adiponectin signaling and beyond. American Journal of Physiology, Endocrinology and Metabolism 2009, 296:E22.
54. Diamanti-Kandarakis E., Papavassiliou A.G., Kandarakis S.A., Chrousos G.P. Pathophysiology and types of dyslipidemia in PCOS. Trends in Endocrinology and Metabolism 2007, 18:280.
55. Douchi T., Ijuin H., Nakamura S., Oki T., Yamamoto S., Nagata Y. Body fat distribution in women with polycystic ovary syndrome. Obstetrics and Gynecology 1995, 86:516.
56. Dupont J., Chabrolle C., Ramé C., Tosca L., Coyral-Castel S. Role of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovary. PPAR Research 2008, 2008:176275.
57. Ebinuma H., Miida T., Yamauchi T., Hada Y., Hara K., Kubota N., et al. Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clinical Chemistry 2007, 53:1541.
58. Elkind-Hirsch K., Marrioneaux O., Bhushan M., Vernor D., Bhushan R. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2008, 93:2670.
59. Escobar-Morreale H.F., Villuendas G., Botella-Carretero J.I., Alvarez-Blasco F., Sanchon R., Luque-Ramirez M., et al. Adiponectin and resistin in PCOS: A clinical, biochemical and molecular genetic study. Human Reproduction 2006, 21:2257.
60. Fasshauer M., Bluher M., Stumvoll M., Tonessen P., Faber R., Stepan H. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clinical Endocrinology 2007, 66:434.
61. Fasshauer M., Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46:1594.
62. Fasshauer M., Waldeyer T., Seeger J., Schrey S., Ebert T., Kratzsch J., et al. Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. European Journal of Endocrinology 2008, 158:197.
63. Filippi E., Sentinelli F., Trischitta V., Romeo S., Arca M., Leonetti F., et al. Association of the human adiponectin gene and insulin resistance. European Journal of Human Genetics 2004, 12:199.
64. Fischer S., Santos A.N., Thieme R., Ramin N., Fischer B. Adiponectin stimulates glucose uptake in rabbit blastocysts. Biology of Reproduction 2010, 83:859.
65. Frish R.E. Body fat, puberty and fertility. Biological Reviews 1984, 59:161.
66. Fry M., Smith P.M., Hoyda T.D., Duncan M., Ahima R.S., Sharkey K.A., et al. Area postrema neurons are modulated by the adipocyte hormone adiponectin. Journal of Neuroscience 2006, 26:9695.
67. Gavrila A., Chan J.L., Yiannakouris N., Kontogianni M., Miller L.C., Orlova C., et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: Cross-sectional and interventional studies. Journal of Clinical Endocrinology and Metabolism 2003, 88:4823.
68. Georgiou H.M., Lappas M., Georgiou G.M., Marita A., Bryant V.J., Hiscock R., et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetologica 2008, 45:157.
69. Glintborg D., Andersen M., Hagen C., Frystyk J., Hulstrom V., Flyvbjerg A., et al. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. European Journal of Endocrinology 2006, 155:337.
70. Glintborg D., Frystyk J., Hojlund K., Andersen K.K., Henriksen J.E., Hermann A.P., et al. Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome. Clinical Endocrinology 2008, 68:165.
71. Goran M.I., Gower B.A. Longitudinal study on pubertal insulin resistance. Diabetes 2001, 50:2444.
72. Gui Y., Silha J.V., Murphy L.J. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obesity Research 2004, 12:1481.
73. Guillod-Maximin E., Roy A.F., Vacher C.M., Aubourg A., Bailleux V., Lorsignol A., et al. Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. The Journal of Endocrinology 2009, 200:93.
74. Gulcelik N.E., Aral Y., Serter R., Demir Y., Culha C. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome. Gynecological Endocrinology 2006, 22:511.
75. Gulcelik N.E., Aral Y., Serter R., Koc G. Association of hypoadiponectinemia with metabolic syndrome in patients with polycystic ovary syndrome. Journal of the National Medical Association 2008, 100:64.
76. Gutman G., Barak V., Maslovitz S., Amit A., Lessing J.B., Geva E. Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: Implications for enhanced insulin sensitivity. Fertility and Sterility 2009, 91:1837.
77. Haap M., Machicao F., Stefan N., Thamer C., Tschritter O., Schnuck F., et al. Genetic determinants of insulin action in polycystic ovary syndrome. Experimental and Clinical Endocrinology & Diabetes 2005, 113:275.
78. Hall N., White C., O'Sullivan A.J. The relationship between adiponectin, progesterone, and temperature across the menstrual cycle. Journal of Endocrinological Investigation 2009, 32:279.
79. Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51:536.
80. Haugen F., Ranheim T., Harsem N.K., Lips E., Staff A.C., Drevon C.A. Increased plasma levels of adipokines in preeclampsia: Relationship to placenta and adipose tissue gene expression. American Journal of Physiology, Endocrinology and Metabolism 2006, 290:E326.
81. Hebbard L.W., Garlatti M., Young L.J., Cardiff R.D., Oshima R.G., Ranscht B. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Research 2008, 68:1407.
82. Heinonen S., Korhonen S., Helisalmi S., Koivunen R., Tapanainen J., Hippelainen M., et al. Associations between two single nucleotide polymorphisms in the adiponectin gene and polycystic ovary syndrome. Gynecological Endocrinology 2005, 21:165.
83. Hendler I., Blackwell S.C., Mehta S.H., Whitty J.E., Russell E., Sorokin Y., et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. American Journal of Obstetrics and Gynecology 2005, 193:979.
84. Herse F., Youpeng B., Staff A.C., Yong-Meid J., Dechend R., Rong Z. Circulating and uteroplacental adipocytokine concentrations in preeclampsia. Reproductive Sciences 2009, 16:584.
85. Hong S.C., Yoo S.W., Cho G.J., Kim T., Hur J.Y., Park Y.K., et al. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause 2007, 14:835.
86. Horenburg S., Fischer-Posovszky P., Debatin K.M., Wabitsch M. Influence of sex hormones on adiponectin expression in human adipocytes. Hormone and Metabolic Research 2008, 40:779.
87. Hoyda T.D., Fry M., Ahima R.S., Ferguson A.V. Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus. The Journal of Physiology 2007, 585:805.
88. Hu E., Liang P., Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. The Journal of Biological Chemistry 1996, 271:10697.
89. Huang K.C., Lue B.H., Yen R.F., Shen C.G., Ho S.R., Tai T.Y., et al. Plasma adiponectin levels and metabolic factors in nondiabetic adolescents. Obesity Research 2004, 12:119.
90. Hug C., Wang J., Ahmad N.S., Bogan J.S., Tsao T.S., Lodish H.F. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:10308.
91. Ibanez L., Sebastiani G., Lopez-Bermejo A., Diaz M., Gomez-Roig M.D., de Zegher F. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: Relation to prenatal growth. The Journal of Clinical Endocrinology and Metabolism 2008, 93:2774.
92. Ichida K., Moriyama T., Morita H., Kondo T., Yoshida S., Ohara N., et al. Plasma adiponectin concentrations and placental adiponectin expression in pre-eclamptic women. Gynecological Endocrinology 2007, 23:238.
93. Im J.A., Lee J.W., Lee H.R., Lee D.C. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy. Maturitas 2006, 54:65.
94. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52:1655.
95. Jakubowska J., Bohdanowicz-Pawlak A., Milewicz A., Szymczak J., Bednarek-Tupikowska G., Demissie M. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. Gynecological Endocrinology 2008, 24:378.
96. Jarvenpaa J., Vuoristo J.T., Santaniemi M., Ukkola O., Savolainen E.R., Jaaskelainen M., et al. Adiponectin induced placental cell apoptosis could be mediated via the ADIPOR1-receptor in pre-eclampsia with IUGR. Journal of Perinatal Medicine 2009, 37:257.
97. Kaaja R.J. Metabolic syndrome and the menopause. Menopause International 2008, 14:21.
98. Kajantie E., Kaaja R., Ylikorkala O., Andersson S., Laivuori H. Adiponectin concentrations in maternal serum: Elevated in preeclampsia but unrelated to insulin sensitivity. Journal of the Society for Gynecologic Investigation 2005, 12:433.
99. Kamoda T., Saitoh H., Saito M., Sugiura M., Matsui A. Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatric Research 2004, 56:690.
100. Kanaley J.A., Sames C., Swisher L., Swick A.G., Ploutz-Snyder L.L., Steppan C.M., et al. Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status. Metabolism 2001, 50:976.
101. Kaplowitz P.B., Slora E.J., Wasserman R.C., Pedlow S.E. Earlier onset of puberty in girls: Relation to increased body mass index and race. Pediatrics 2001, 108:347.
102. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. The Journal of Clinical Endocrinology and Metabolism 2000, 85:2402.
103. Kim S.T., Marquard K., Stephens S., Louden E., Allsworth J., Moley K.H. Adiponectin and adiponectin receptors in the mouse preimplantation embryo and uterus. Human Reproduction 2011, 26:82.
104. Kirchengast S., Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Human Reproduction 2001, 16:1255.
105. Kleiblova P., Springer D., Haluzik M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiological Research 2006, 55:661.
106. Koga K., Osuga Y., Yoshino O., Hirota Y., Ruimeng X., Hirata T., et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. Journal of Clinical Endocrinology and Metabolism 2003, 88:2348.
107. Komar C.M. Peroxisome proliferator-activated receptors (PPARs) and ovarian function-Implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reproductive Biology and Endocrinology 2005, 3:41.
108. Kos K., Harte A.L., da Silva N.F., Tonchev A., Chaldakov G., James S., et al. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 2007, 92:1129.
109. Kusminski C.M., McTernan P.G., Schraw T., Kos K., O'Hare J.P., Ahima R., et al. Adiponectin complexes in human cerebrospinal fluid: Distinct complex distribution from serum. Diabetologia 2007, 50:634.
110. Kyriakakou M., Malamitsi-Puchner A., Militsi H., Boutsikou T., Margeli A., Hassiakos D., et al. Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers. European Journal of Endocrinology 2008, 158:343.
111. Lagaly D.V., Aad P.Y., Grado-Ahuir J.A., Hulsey L.B., Spicer L.J. Role of adiponectin in regulating ovarian theca and granulosa cell function. Molecular and Cellular Endocrinology 2008, 284:38.
112. Lara-Castro C., Luo N., Wallace P., Klein R.L., Garvey W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55:249.
113. Ledoux S., Campos D.B., Lopes F.L., Dobias-Goff M., Palin M.F., Murphy B.D. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 2006, 147:5178.
114. Lee C.G., Carr M.C., Murdoch S.J., Mitchell E., Woods N.F., Wener M.H., et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: A prospective study. Journal of Clinical Endocrinology and Metabolism 2009, 94:1104.
115. Lee M.H., Klein R.L., El-Shewy H.M., Luttrell D.K., Luttrell L.M. The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry 2008, 47:11682.
116. Leff T. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochemical Society Transactions 2003, 31:224.
117. Leung K.C., Xu A., Craig M.E., Martin A., Lam K.S.L., O'Sullivan A.J. Adiponectin isoform distribution in women-relationship to female sex steroids and insulin sensitivity. Metabolism 2009, 58:239.
118. Levy-Marchal C., Jaquet D. Long-term metabolic consequences of being born small for gestational age. Pediatric Diabetes 2004, 5:147.
119. Li L., Yun J.H., Lee J.H., Song S., Choi B.C., Baek K.H. Association study of +45G15G(T/G) and +276(G/T) polymorphisms in the adiponectin gene in patients with polycystic ovary syndrome. International Journal of Molecular Medicine 2011, 27:283.
120. Liu Y.H., Tsai E.M., Wu L.C., Chen S.Y., Chang Y.H., Jong S.B., et al. Higher basal adiponectin levels are associated with better ovarian response to gonadotropin stimulation during in vitro fertilization. Gynecologic and Obstetric Investigation 2005, 60:167.
121. Lobo R.A. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008, 60:10.
122. Lord E., Ledoux S., Murphy B.D., Beaudry D., Palin M.F. Expression of adiponectin and its receptors in swine. Journal of Animal Science 2005, 83:565.
123. Low C.F., Tohit E.R.M., Chong P.P., Idris F. Adiponectin SNP45TG is associated with gestational diabetes mellitus. Archives of Gynecology and Obstetrics 2011, 283:1255.
124. Lu M., Tang Q., Olefsky J.M., Mellon P.L., Webster N.J.G. Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes. Molecular Endocrinology 2008, 22:760.
125. Lu D., Yang X., Wu Y., Wang H., Huang H., Dong M. Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. International Journal of Gynaecology and Obstetrics 2006, 95:121.
126. Luque-Ramirez M., Alvarez-Blasco F., Escobar-Morreale H.F. Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients. Obesity 2009, 17:3.
127. Maddineni S., Metzger S., Ocon O., Hendricks G., Ramachandran R. Adiponectin gene is expressed in multiple tissues in the chicken: Food deprivation influences adiponectin messenger ribonucleic acid expression. Endocrinology 2005, 146:4250.
128. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochemical and Biophysical Research Communications 1996, 221:286.
129. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 2002, 8:731.
130. Maillard V., Uzbekova S., Guignot F., Perreau C., Rame C., Coyral-Castel S., et al. Effect of adiponectin on bovine granulosa cell steroidogenesis, oocyte maturation and embryo development. Reproductive Biology and Endocrinology 2010, 8:23.
131. Majuri A., Santaniemi M., Rautio K., Kunnari A., Vartiainen J., Ruokonen A., et al. Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: A randomized placebo-controlled study. European Journal of Endocrinology 2007, 156:263.
132. Mao X., Kikani C.K., Riojas R.A., Langlais P., Wang L., Ramos F.J., et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nature Cell Biology 2006, 8:516.
133. Martinez-Cordero C., Amador-Licona N., Guizar-Mendoza J.M., Hernandez-Mendez J., Ruelas-Orozco G. Body fat at birth and cord blood levels of insulin, adiponectin, leptin, and insulin-like growth factor-I in small-for-gestational-age infants. Archives of Medical Research 2006, 37:490.
134. Martos-Moreno G.A., Barrios V., Argente J. Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: Relationship with sex steroids. European Journal of Endocrinology 2006, 155:429.
135. Martos-Moreno G.A., Barrios V., de Pipaon M.S., Pozo J., Dorronsoro I., Martinez-Biarge M., et al. Influence of prematurity and growth restriction on the adipokine profile, IGF1, and ghrelin levels in cord blood: Relationship with glucose metabolism. European Journal of Endocrinology 2009, 161:381.
136. Masuyama H., Hiramatsu Y. Angiogenic proteins and adipocytokines as markers for prediction of preeclampsia. Expert Review of Obstetrics and Gynecology 2010, 5:717.
137. Masuyama H., Segawa T., Sumida Y., Masumoto A., Inoue S., Akahori Y., et al. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. BJOG: An International Journal of Obstetrics and Gynaecology 2010, 117:314.
138. Matsubara M., Maruoka S., Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. European Journal of Endocrinology 2002, 147:173.
139. Maury E., Ehala-Aleksejev K., Guiot Y., Detry R., Vandenhooft A., Brichard S.M. Adipokines oversecreted by omental adipose tissue in human obesity. American Journal of Physiology, Endocrinology and Metabolism 2007, 293:E656.
140. Maynard S.E., Karumanchi S.A. Angiogenic factors and preeclampsia. Seminars in Nephrology 2011, 31:33.
141. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. The Journal of Clinical Investigation 2003, 111:649.
142. Mazaki-Tovi S., Romero R., Vaisbuch E., Erez O., Mittal P., Chaiworapongsa T., et al. Maternal serum adiponectin multimers in gestational diabetes. Journal of Perinatal Medicine 2009, 37:637.
143. Mazaki-Tovi S., Romero R., Vaisbuch E., Kusanovic J.P., Erez O., Gotsch F., et al. Maternal serum adiponectin multimers in preeclampsia. Journal of Perinatal Medicine 2009, 37:349.
144. McDonald E.A., Wolfe M.W. Adiponectin attenuation of endocrine function within human term trophoblast cells. Endocrinology 2009, 150:4358.
145. Merki-Feld G.S., Imthurn B., Rosselli M., Spanaus K. Serum concentrations of high-molecular weight adiponectin and their association with sex steroids in premenopausal women. Metabolism 2011, 60:180.
146. Michalakis K.G., Segars J.H. The role of adiponectin in reproduction: From polycystic ovary syndrome to assisted reproduction. Fertility and Sterility 2010, 94:1949.
147. Moore R.K., Otsuka F., Shimasaki S. Role of ERK1/2 in the differential synthesis of progesterone and estradiol by granulosa cells. Biochemical and Biophysical Research Communications 2001, 289:796.
148. Moran A., Jacobs D.R., Steinberger J., Hong C.P., Prineas R., Luepker R.V., et al. Insulin resistance during puberty: Results from clamp studies in 357 children. Diabetes 1999, 48:2039.
149. Moran L.J., Misso M.L., Wild R.A., Norman R.J. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Human Reproduction Update 2010, 16:347.
150. Mori T., Shinohara K., Wakatsuki A., Watanabe K., Fujimaki A. Adipocytokines and endothelial function in preeclamptic women. Hypertension Research 2010, 33:250.
151. Nakano Y., Tobe T., Choi-Miura N.H., Mazda T., Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. Journal of Biochemistry 1996, 120:803.
152. Nakashima R., Kamei N., Yamane K., Nakanishi S., Nakashima A., Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. Journal of Clinical Endocrinology and Metabolism 2006, 91:3873.
153. Naruse K., Yamasaki M., Umekage H., Sado T., Sakamoto Y., Morikawa H. Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. Journal of Reproductive Immunology 2005, 65:65.
154. Nawrocki A.R., Rajala M.W., Tomas E., Pajvani U.B., Saha A.K., Trumbauer M.E., et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. Journal of Biological Chemistry 2006, 281:2654.
155. Neumeier M., Weigert J., Buettner R., Wanninger J., Schaffler A., Muller A.M., et al. Detection of adiponectin in cerebrospinal fluid in humans. American Journal of Physiology, Endocrinology and Metabolism 2007, 293:E965.
156. Nien J.K., Mazaki-Tovi S., Romero R., Erez O., Kusanovic J.P., Gotsch F., et al. Adiponectin in severe preeclampsia. Journal of Perinatal Medicine 2007, 35:503.
157. Nien J.K., Mazaki-Tovi S., Romero R., Erez O., Kusanovic J.P., Gotsch F., et al. Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women. Journal of Perinatal Medicine 2007, 35:522.
158. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51:2734.
159. Norman R.J., Dewailly D., Legro R.S., Hicket T.E. Polycystic ovary syndrome. Lancet 2007, 370:685.
160. O'Brien T.E., Ray J.G., Chan W.S. Maternal body mass index and the risk of preeclampsia: A systematic overview. Epidemiology 2003, 14:368.
161. O'Connor A., Phelan N., Kyaw Tun T., Boran G., Gibney J., Roche H.M. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. Journal of Clinical Endocrinology and Metabolism 2010, 95:1378.
162. Odden N., Morkrid L. High molecular weight adiponectin dominates in cord blood of newborns but is unaffected by pre-eclamptic pregnancies. Clinical Endocrinology 2007, 67:891.
163. Ogland B., Romundstad P.R., Vefring H., Forman M.R., Nilsen S.T., Vatten L.J. Preeclampsia and adiponectin in cord blood. Hormone Research in Paediatrics 2010, 74:92.
164. Ong K.K., Petry C.J., Emmett P.M., Sandhu M.S., Kiess W., Hales C.N., et al. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 2004, 47:1064.
165. Orio F., Palomba S., Cascella T., Milan G., Mioni R., Pagano C., et al. Adiponectin levels in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003, 88:2619.
166. Ortega H.H., Rey F., Velazquez M.M.L., Padmanabhan V. Developmental programming: Effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep. Biology of Reproduction 2010, 82:1065.
167. Ouchi N., Kobayashi H., Kihara S., Kumada M., Sato K., Inoue T., et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. Journal of Biological Chemistry 2004, 279:1304.
168. Ouyang Y., Chen H., Chen H. Reduced plasma adiponectin and elevated leptin in pre-eclampsia. International Journal of Gynecology & Obstetrics 2007, 98:110.
169. Pajvani U.B., Du X., Combs T.P., Berg A.H., Rajala M.W., Schulthess T., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. Journal of Biological Chemistry 2003, 278:9073.
170. Pajvani U.B., Hawkins M., Combs T.P., Rajala M.W., Doebber T., Berger J.P., et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry 2004, 279:12152.
171. Pan W., Tu H., Kastin A.J. Differential BBB interactions of three ingestive peptides: Obestatin, ghrelin, and adiponectin. Peptides 2006, 27:911.
172. Panidis D., Kourtis A., Farmakiotis D., Mouslech T., Rousso D., Koliakos G. Serum adiponectin levels in women with polycystic ovary syndrome. Human Reproduction 2003, 18:1790.
173. Panidis D., Kourtis A., Kukuvitis A., Farmakiotis D., Xita N., Georgiou I., et al. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: Role of Delta4-androstenedione. Human Reproduction 2004, 19:1728.
174. Paradisi G., Ianniello F., Tomei C., Bracaglia M., Carducci B., Gualano M.R., et al. Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes. Gynecological Endocrinology 2010, 26:539.
175. Peake P.W., Kriketos A.D., Campbell L.V., Shen Y., Charlesworth J.A. The metabolism of isoforms of human adiponectin: Studies in human subjects and in experimental animals. European Journal of Endocrinology 2005, 153:409.
176. Petersen S., Gotfredsen A., Knudsen F.U. Lean body mass in small for gestational age and appropriate for gestational age infants. Journal of Pediatrics 1988, 113:886.
177. Peterson J.M., Wei Z., Wong G.W. C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. Journal of Biological Chemistry 2010, 285:39691.
178. Petrone A., Zavarella S., Caiazzo A., Leto G., Spoletini M., Potenziani S., et al. The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity. Obesity 2006, 14:1498.
179. Pierre P., Froment P., Nègre D., Ramé C., Barateau V., Chabrolle C., et al. Role of adiponectin receptors, AdipoR1 and AdipoR2, in the steroidogenesis of the human granulosa tumor cell line, KGN. Human Reproduction 2009, 24:2890.
180. Punthakee Z., Delvin E.E., O'Loughlin J., Paradis G., Levy E., Platt R.W., et al. Adiponectin, adiposity, and insulin resistance in children and adolescents. Journal of Clinical Endocrinology and Metabolism 2006, 91:2119.
181. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., et al. Adiponectin acts in the brain to decrease body weight. Nature Medicine 2004, 10:524.
182. Ramachandran R., Ocon-Grove O.M., Metzger S.L. Molecular cloning and tissue expression of chicken AdipoR1 and AdipoR2 complementary deoxyribonucleic acids. Domestic Animal Endocrinology 2007, 33:19.
183. Ramsay J.E., Jamieson N., Greer I.A., Sattar N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension 2003, 42:891.
184. Ranheim T., Haugen F., Staff A.C., Braekke K., Harsem N., Drevon C.A. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstetricia et Gynecologica Scandinavica 2004, 83:341.
185. Ranjzad F., Mahmoudi T., Shemirani A.I., Mahban A., Nikzamir A., Vahedi M., et al. A common variant in the adiponectin gene and polycystic ovary syndrome risk. Molecular Biology Reports 2011, 39:2313.
186. Retnakaran R., Connelly P.W., Maguire G., Sermer M., Zinman B., Hanley A.J.G. Decreased high-molecular-weight adiponectin in gestational diabetes: Implications for the pathophysiology of Type 2 diabetes. Diabetic Medicine 2007, 24:245.
187. Robinson R.S., Woad K.J., Hammond A.J., Laird M., Hunter M.G., Mann G.E. Angiogenesis and vascular function in the ovary. Reproduction 2009, 138:869.
188. Robitaille J., Grant A.M. The genetics of gestational diabetes mellitus: Evidence for relationship with type 2 diabetes mellitus. Genetics in Medicine 2008, 10:240.
189. Rodriguez-Pacheco F., Martinez-Fuentes A.J., Tovar S., Pinilla L., Tena-Sempere M., Dieguez C., et al. Regulation of pituitary cell function by adiponectin. Endocrinology 2007, 148:401.
190. Rouen P.A., Lukacs J.L., Reame N.E. Adipokine concentrations in nonobese women: A study of reproductive aging, body mass index, and menstrual cycle effects. Biological Research for Nursing 2010, 12:54.
191. Ruchat S.M., Loos R.J., Rankinen T., Vohl M.C., Weisnagel S.J., Despres J.P., et al. Associations between glucose tolerance, insulin sensitivity and insulin secretion phenotypes and polymorphisms in adiponectin and adiponectin receptor genes in the Quebec Family Study. Diabetic Medicine 2008, 25:400.
192. Sawidou M.D., Nelson S.M., Makgoba M., Messow C.M., Sattar N., Nicolaides K. First-trimester prediction of gestational diabetes mellitus: Examining the potential of combining maternal characteristics and laboratory measures. Diabetes 2010, 59:3017.
193. Sawidou M.D., Sotiriadis A., Kaihura C., Nicolaides K.H., Sattar N. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction. Clinical Science 2008, 115:219.
194. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 1995, 270:26746.
195. Schmidt T., Fischer S., Tsikolia N., Navarrete Santos A., Rohrbach S., Ramin N., et al. Expression of adipokines in preimplantation rabbit and mice embryos. Histochemistry and Cell Biology 2008, 129:817.
196. Schnatz P.F., Schnatz J.D. Dyslipidemia in menopause: Mechanisms and management. Obstetrical and Gynecological Survey 2006, 61:608.
197. Schoppen S., Riestra P., Garcia-Anguita A., Lopez-Simon L., Cano B., de Oya I., et al. Leptin and adiponectin levels in pubertal children: Relationship with anthropometric variables and body composition. Clinical Chemistry and Laboratory Medicine 2010, 48:707.
198. Sekar N., Garmey J.C., Veldhuis J.D. Mechanisms underlying the steroidogenic synergy of insulin and luteinizing hormone in porcine granulosa cells: Joint amplification of pivotal sterol-regulatory genes encoding the low-density lipoprotein (LDL) receptor, steroidogenic acute regulatory (stAR) protein and cytochrome P450 side-chain cleavage (P450scc) enzyme. Molecular and Cellular Endocrinology 2000, 159:25.
199. Sepilian V., Nagamani M. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. Journal of the Society for Gynecologic Investigation 2005, 12:129.
200. Shi Q.J., Lei Z.M., Rao Ch.V., Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 1993, 132:1387.
201. Shroff R., Kerchner A., Maifeld M., Van Beek E.J., Jagasia D., Dokras A. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. Journal of Clinical Endocrinology and Metabolism 2007, 92:4609.
202. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785.
203. Sieminska L., Marek B., Kos-Kudla B., Niedziolka D., Kajdaniuk D., Nowak M., et al. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. Journal of Endocrinological Investigation 2004, 27:528.
204. Sieminska L., Wojciechowska C., Niedziolka D., Marek B., Kos-Kudla B., Kajdaniuk D., et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism 2005, 54:1610.
205. Sir-Petermann T., Maliqueo M., Codner E., Echiburu B., Crisosto N., Perez V., et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007, 92:4637.
206. Soheilykhah S., Mohammadi M., Mojibian M., Rahimi-Saghand S., Rashidi M., Hadinedoushan H., et al. Maternal serum adiponectin concentration in gestational diabetes. Gynecological Endocrinology 2009, 25:593.
207. Soni A.C., Conroy M.B., Mackey R.H., Kuller L.H. Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight, postmenopausal women. Menopause 2011, 18:296.
208. Soto N., Bazaes R.A., Pena V., Salazar T., Avila A., Iniguez G., et al. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: Results from a prospective cohort. Journal of Clinical Endocrinology and Metabolism 2003, 88:3645.
209. Sowers M.F., Wildman R.P., Mancuso P., Eyvazzadeh A.D., Karvonen-Gutierrez C.A., Rillamas-Sun E., et al. Change in adipocytokines and ghrelin with menopause. Maturitas 2008, 59:149.
210. Spranger J., Mohlig M., Wegewitz U., Ristow M., Pfeiffer A.F.H., Schill T., et al. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clinical Endocrinology 2004, 61:738.
211. Spranger J., Verma S., Gohring I., Bobbert T., Seifert J., Sindler A.L., et al. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006, 55:141.
212. Steiner C.A., Janez A., Jensterle M., Reisinger K., Forst T., Pfutzner A. Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. Journal of Diabetes Science and Technology 2007, 1:211.
213. Street M.E., Volta C., Ziveri M.A., Viani I., Bernasconi S. Markers of insulin sensitivity in placentas and cord serum of intrauterine growth-restricted newborns. Clinical Endocrinology 2009, 71:394.
214. Stumvoll M., Tschritter O., Fritsche A., Staiger H., Renn W., Weisser M., et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: Interaction with family history of type 2 diabetes. Diabetes 2002, 51:37.
215. Sumino H., Takahashi T., Itoh T., Kusaka K., Yamakawa J., Ichikawa S., et al. Plasma adiponectin levels in post-menopausal women receiving hormone replacement therapy. The Journal of International Medical Research 2004, 32:639.
216. Sun X., He J., Mao C., Han R., Wang Z., Liu Y., et al. Negative regulation of adiponectin receptor 1 promoter by insulin via a repressive nuclear inhibitory protein element. FEBS Letters 2008, 582:3401.
217. Tabandeh M.R., Hosseini A., Saeb M., Kafi M., Saeb S. Changes in the gene expression of adiponectin and adiponectin receptors (AdipoR1 and AdipoR2) in ovarian follicular cells of dairy cow at different stages of development. Theriogenology 2010, 73:659.
218. Takaya J., Yamato F., Higashino H., Kaneko K. Intracellular magnesium and adipokines in umbilical cord plasma and infant birth size. Pediatric Research 2007, 62:700.
219. Takemura Y., Osuga Y., Yamauchi T., Kobayashi M., Harada M., Hirata T., et al. Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology 2006, 147:3203.
220. Tang Y.T., Hu T., Arterburn M., Boyle B., Bright J.M., Emtage P.C., et al. PAQR proteins: A novel membrane receptor family defined by an ancient 7-transmembrane pass motif. Journal of Molecular Evolution 2005, 61:372.
221. Tersigni C., Di Nicuolo F., D'Ippolito S., Veglia M., Castellucci M., Di Simone N. Adipokines: New emerging roles in fertility and reproduction. Obstetrical and Gynecological Survey 2011, 66:47.
222. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004, 19:41.
223. The ESHRE Capri Workshop Group Nutrition and reproduction in women. Human Reproduction Update 2006, 12:193.
224. Tomlinson J., Millward A., Stenhouse E., Pinkey J. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: What are the risks and can they be reduced?. Diabetic Medicine 2010, 27:498.
225. Tosca L., Froment P., Solnais P., Ferre P., Foufelle F., Dupont J. Adenosine 5'-monophosphate-activated protein kinase regulates progesterone secretion in rat granulosa cells. Endocrinology 2005, 146:4500.
226. Toulis K.A., Goulis D.G., Farmakiotis D., Georgopoulos N.A., Katsikis I., Tarlatzis B.C., et al. Adiponectin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis. Human Reproduction Update 2009, 15:297.
227. Travers S.H., Jeffers B.W., Bloch C.A., Hill J.O., Eckel R.H. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. Journal of Clinical Endocrinology and Metabolism 1995, 80:172.
228. Trayhurn P., Wood I.S. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004, 92:347.
229. Trolle B., Lauszus F.F., Frystyk J., Flyvbjerg A. Adiponectin levels in women with polycystic ovary syndrome: Impact of metformin treatment in a randomized controlled study. Fertility and Sterility 2010, 94:2234.
230. Trujillo M.E., Scherer P.E. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. Journal of Internal Medicine 2005, 257:167.
231. Tsai P.J., Yu C.H., Hsu S.P., Lee Y.H., Huang I.T., Ho S.C., et al. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: Negative association with gestational diabetes mellitus. Nutrition 2005, 21:1095.
232. Tsuchiya K., Akaza I., Yoshimoto T., Hirata Y. Pioglitazone improves endothelial function with increased adiponectin and high-density lipoprotein cholesterol levels in type 2 diabetes. Endocrine Journal 2009, 56:691.
233. Tuuli M.G., Odibo A.O. First- and second-trimester screening for preeclampsia and intrauterine growth restriction. Clinics in Laboratory Medicine 2010, 30:727.
234. Unluturk U., Harmanci A., Kocaefe C., Yildiz B.O. The genetic basis of the polycystic ovary syndrome: A literature review including discussion of PPAR-gamma. PPAR Research 2007, 2007:49109.
235. Van Binsbergen C.J., Voelingh Bennink H.J., Odink J., Haspels A.A., Koppeschaar H.P. A comparative and longitudinal study on endocrine changes related to ovarian function in patients with anorexia nervosa. The Journal of Clinical Endocrinology and Metabolism 1990, 71:705.
236. Vink J.M., Sadrzadeh S., Lambalk C.B., Boomsma D.I. Heritability of polycystic ovary syndrome in a Dutch twin-family study. Journal of Clinical Endocrinology and Metabolism 2006, 91:2100.
237. Vitoratos N., Deliveliotou A., Vlahos N.F., Mastorakos G., Papadias K., Botsis D., et al. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecological Endocrinology 2008, 24:614.
238. Vrbikova J., Dvorakova K., Hill M., Vcelak J., Stanicka S., Vankova M., et al. Determinants of circulating adiponectin in women with polycystic ovary syndrome. Gynecologic and Obstetric Investigation 2005, 60:155.
239. Wang J., Shang L.X., Dong X., Wang X., Wu N., Wang S.H., et al. Relationship of adiponectin and resistin levels in umbilical serum, maternal serum and placenta with neonatal birth weight. The Australian and New Zealand Journal of Obstetrics and Gynaecology 2010, 50:432.
240. Wen J.P., Lv W.S., Yang J., Nie A.F., Cheng X.B., Yang Y., et al. Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential. Biochemical and Biophysical Research Communications 2008, 371:756.
241. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001, 86:1930.
242. Whitworth K.M., Agca C., Kim J.G., Patel R.V., Springer G.K., Bivens N.J., et al. Transcriptional profiling of pig embryogenesis by using a 15-K member unigene set specific for pig reproductive tissues and embryos. Biology of Reproduction 2005, 72:1437.
243. WHO Attending to 136 million births, every year. World health report: Make every mother and child count 2005, WHO, Geneva, p. 41.
244. Wickham E.P., Cheang K.I., Clore J.N., Baillargeon J.P., Nestler J.E. Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome. Metabolism 2011, 60:366.
245. Wong G.W., Krawczyk S.A., Kitidis-Mitrokostas C., Ge G., Spooner E., Hug C., et al. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. The FASEB Journal 2009, 23:241.
246. Wong G.W., Krawczyk S.A., Kitidis-Mitrokostas C., Revett T., Gimeno R., Lodish H.F. Molecular, biochemical and functional characterizations of C1q/TNF family members: Adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochemical Journal 2008, 416:161.
247. Wong G.W., Wang J., Hug C., Tsao T.S., Lodish H.F. A family of Acrp30/adiponectin structural and functional paralogs. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:10302.
248. Woo J.G., Dolan L.M., Daniels S.R., Goodman E., Martin L.J. Adolescent sex differences in adiponectin are conditional on pubertal development and adiposity. Obesity Research 2005, 13:2095.
249. Worda C., Leipold H., Gruber C., Kautzky-Willer A., Knofler M., Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 2004, 191:2120.
250. Xita N., Georgiou I., Chatzikyriakidou A., Vounatsou M., Papassotiriou G.P., Papassotiriou I., et al. Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clinical Chemistry 2005, 51:416.
251. Yajnik C.S., Lubree H.G., Rege S.S., Naik S.S., Deshpande J.A., Deshpande S.S., et al. Adiposity and hyperinsulinemia in Indians are present at birth. Journal of Clinical Endocrinology and Metabolism 2002, 87:5575.
252. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762.
253. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. Journal of Clinical Endocrinology and Metabolism 2001, 86:3815.
254. Yoshihara K., Yahata T., Kashima K., Mikami T., Tanaka K. Association of single nucleotide polymorphisms in adiponectin and its receptor genes with polycystic ovary syndrome. The Journal of Reproductive Medicine 2009, 54:669.
255. Zhang N., Shi Y.H., Hao C.F., Gu H.F., Li Y., Zhao Y.R., et al. Association of 45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women. European Journal of Endocrinology 2008, 158:255.